Search

Displaying results 7921 - 7930 of 10000 in total
  1. Drug

    Lodenafil carbonate

    go.drugbank.com/drugs/DB11927
    Investigational

    Lodenafil carbonate has been used in trials studying the treatment of Coronaropathy and Erectile Dysfunction.

  2. Drug

    Fosdagrocorat

    go.drugbank.com/drugs/DB12198
    Investigational

    Fosdagrocorat has been used in trials studying the treatment and basic science of Rheumatoid Arthritis.

  3. Drug

    Edicotinib

    go.drugbank.com/drugs/DB12504
    Investigational

    JNJ-40346527 has been used in trials studying the treatment of Health and Arthritis, Rheumatoid.

  4. Drug

    AZD-9056

    go.drugbank.com/drugs/DB12594
    Investigational

    AZD9056 has been used in trials studying the basic science and treatment of Rheumatoid Arthritis.

  5. Drug

    Ruzasvir

    go.drugbank.com/drugs/DB11713
    Investigational

    Ruzasvir has been used in trials studying the treatment of Hepatitis C, Hepatitis C, Chronic, and Hepatitis C Infection.

  6. Drug

    Marizomib

    go.drugbank.com/drugs/DB11762
    Investigational

    Marizomib has been used in trials studying the treatment of Cancer, Melanoma, Lymphoma, Glioblastoma, and Malignant Glioma, among others.

  7. Drug

    Crenolanib

    go.drugbank.com/drugs/DB11832
    Investigational

    Crenolanib is under investigation for the treatment of Diffuse Intrinsic Pontine Glioma and Progressive or Refractory High-Grade Glioma.

  8. Drug

    Ceralasertib

    go.drugbank.com/drugs/DB14917
    Investigational

    Ceralasertib is under investigation in clinical trial NCT03682289 (Phase II Trial of AZD6738 Alone and in Combination With Olaparib).

  9. Drug

    Necuparanib

    go.drugbank.com/drugs/DB16251
    Investigational

    Necuparanib is under investigation in clinical trial NCT01621243 (M402 in Combination With Nab-paclitaxel and Gemcitabine in Pancreatic Cancer).

  10. Drug

    Gefurulimab

    go.drugbank.com/drugs/DB18928
    Investigational

    Gefurulimab is under investigation in clinical trial NCT05556096 (Safety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia Gravis).